Abstract

Over 130 brain diseases are caused by mutations that disrupt genes encoding the proteome of excitatory synapses. These include neurological and psychiatric disorders with early and late onset such as autism, schizophrenia and depression and many other rarer conditions. The proteome of synapses is highly complex with over 1000 conserved proteins which are differentially expressed generating a vast, potentially unlimited, number of synapse types. The diversity of synapses and their location in the brain are described by the synaptome. A recent study has mapped the synaptome across the mouse brain, revealing that synapse diversity is distributed into an anatomical architecture observed at scales from individual dendrites to the whole systems level. The synaptome architecture is built from the hierarchical expression and assembly of proteins into complexes and supercomplexes which are distributed into different synapses. Mutations in synapse proteins change the synaptome architecture leading to behavioral phenotypes. Mutations in the mechanisms regulating the hierarchical assembly of the synaptome, including transcription and proteostasis, may also change synapse diversity and synaptome architecture. The logic of synaptome hierarchical assembly provides a mechanistic framework that explains how diverse genetic disorders can converge on synapses in different brain circuits to produce behavioral phenotypes.

Highlights

  • Over 130 brain diseases are caused by mutations that disrupt genes encoding the proteome of excitatory synapses

  • Characterisation of the postsynaptic proteome purified from human brain tissue in 2011 revealed that over 130 brain diseases arise from mutations in hundreds of genes encoding proteins in the postsynaptic proteome of excitatory synapses[5]

  • We found that mutations in PSD93 and SAP102 (Psd93 knockout mice, which are a model of schizophrenia, and Sap102 knockouts, which are a model of X-linked intellectual disability) changed the synaptome map of PSD95 (Figure 3C)

Read more

Summary

Synapse diversity and synaptome architecture in human genetic disorders

Citation for published version: Grant, SGN 2019, 'Synapse diversity and synaptome architecture in human genetic disorders', Human Molecular Genetics. Seth G.N. Grant Centre for Clinical Brain Sciences & Simons Initiative for the Developing Brain (SIDB) Edinburgh University Edinburgh EH16 4SB, UK

Synapse proteome complexity and genetic disorders
Synapses are highly complex and sophisticated signalling machines
From synapse proteome complexity to synapse diversity and the synaptome
Synaptome modification in genetic disorders
The functional importance of synaptome architecture for behaviour
Findings
Concluding comments and future perspectives
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call